Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.49 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27771735 | 0.82 | CA12 (0.58) | PDGFRBPDGFRACA12CA1CA2 | |
| SCHEMBL4889753 | 0.80 | MAP4K4 (0.47) | PDGFRBPDGFRACA12CA1CA2 | |
| SCHEMBL2856840 | 0.79 | CA12 (0.47) | PDGFRBPDGFRACA12CA1CA2 | |
| SCHEMBL16796251 | 0.77 | KMT2A (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8031197 | 0.77 | CA12 (0.49) | CA12CA1CA2ESR1CA7 | |
| SCHEMBL11562618 | 0.77 | LMNA (0.46) | PDGFRBPDGFRACA12CA1CA2 | |
| SCHEMBL4635046 | 0.76 | CA12 (0.63) | PDGFRBPDGFRACA12CA1CA2 | |
| SCHEMBL18832310 | 0.76 | CA12 (0.47) | PDGFRBPDGFRACA12CA1CA2 | |
| SCHEMBL16351874 | 0.76 | CA1 (0.73) | CA12CA1CA2ESR1CA7 | |
| SCHEMBL1965326 | 0.76 | CA1 (0.73) | CA12CA1CA2ESR1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4253412-A2 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | The Walter and Eliza Hall Institute of Medical Research (AU) | 2023-10-04 | — | — | EP | disclosed |
| EP-4253412-A2 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | The Walter and Eliza Hall Institute of Medical Research (AU) | 2023-10-04 | — | — | EP | disclosed |
| US-20230192857-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | WALTER & ELIZA HALL INST MEDICAL RES (AU) | 2023-06-22 | — | — | US | disclosed |
| US-20230192857-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | WALTER & ELIZA HALL INST MEDICAL RES (AU) | 2023-06-22 | — | — | US | disclosed |
| EP-3827838-B1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | WALTER & ELIZA HALL INST MEDICAL RES (AU) | 2023-06-07 | — | — | EP | disclosed |
| EP-3827838-B1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | WALTER & ELIZA HALL INST MEDICAL RES (AU) | 2023-06-07 | — | — | EP | disclosed |
| US-11492404-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 2022-11-08 | — | — | US | disclosed |
| US-20220267447-A1 | Inhibition of Cytokine-Induced SH2 Protein in NK Cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2022-08-25 | — | — | US | disclosed |
| US-11339220-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 2022-05-24 | — | — | US | disclosed |
| US-11339220-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 2022-05-24 | — | — | US | disclosed |
| US-20210171636-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | WALTER & ELIZA HALL INST MEDICAL RES (AU) | 2021-06-10 | — | — | US | disclosed |
| US-20210171636-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | WALTER & ELIZA HALL INST MEDICAL RES (AU) | 2021-06-10 | — | — | US | disclosed |
| EP-3827838-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | The Walter and Eliza Hall Institute of Medical Research (AU) | 2021-06-02 | — | — | EP | disclosed |
| EP-3827838-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | The Walter and Eliza Hall Institute of Medical Research (AU) | 2021-06-02 | — | — | EP | disclosed |
| US-10975149-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 2021-04-13 | — | — | US | disclosed |
| US-10975149-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 2021-04-13 | — | — | US | disclosed |
| EP-3389695-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | The Walter and Eliza Hall Institute of Medical Research (AU) | 2018-10-24 | — | — | EP | disclosed |
| US-20180298101-A1 | Inhibition of Cytokine-Induced SH2 Protein in NK Cells | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2018-10-18 | — | — | US | disclosed |
| WO-2017100861-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017100861-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192857-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | IL2, ILF2, CD74 | PDGFRB 1530/4885PDGFRA 2305/4885CA12 3652/4885 |
| US-11492404-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | IL2, ILF2, LCP2 | PDGFRB 1612/4885PDGFRA 2412/4885CA12 3604/4885 |
| US-20180298101-A1 | Inhibition of Cytokine-Induced SH2 Protein in NK Cells | IL2, ILF2, LCP2 | PDGFRB 1612/4885PDGFRA 2412/4885CA12 3604/4885 |
| US-11339220-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | IL2, ILF2, LCP2 | PDGFRB 1612/4885PDGFRA 2412/4885CA12 3604/4885 |
| US-20210171636-A1 | INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS | IL2, ILF2, CD74 | PDGFRB 1530/4885PDGFRA 2305/4885CA12 3652/4885 |
| US-20220267447-A1 | Inhibition of Cytokine-Induced SH2 Protein in NK Cells | IL2, ILF2, CD74 | PDGFRB 1530/4885PDGFRA 2305/4885CA12 3652/4885 |
| US-10975149-B2 | Inhibition of cytokine-induced SH2 protein in NK cells | IL2, ILF2, LCP2 | PDGFRB 1612/4885PDGFRA 2412/4885CA12 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.